Patent · US Active

HVAD circadian tracker (PHI+)

US10561774B2 · kind B2 · utility

1Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2017
Grant dateFeb 18, 2020
Priority date
Expiry dateNov 9, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/3327
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method of detecting a disruption in a diurnal rhythm of a patient having an implantable blood pump comprising calculating a moving average convergence divergence (MACD) based on power consumed by the implantable blood pump to maintain a constant rotational speed of an impeller of the implantable blood pump and generating an alert when the calculated MACD does not cross a MACD zero line for a predetermined MACD zero line crossing time threshold.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.